Many people may not have heard of the pharmaceutical drug Elmiron. This medication is the only prescription drug approved to treat interstitial cystitis, commonly known as bladder pain syndrome (BPS). Recent studies have called into question the long-term safety of this pharmaceutical drug. At Colson Hicks Eidson, we have been nationally recognized for our work on behalf of clients harmed by defective pharmaceuticals. When you need an Elmiron attorney in Miami, or anywhere in the United States, call us today.
Pharmaceutical drugs come with warnings
Any prescription drug sold and distributed in the United States must first be approved by the US Food and Drug Administration (FDA). The FDA will only approve a prescription drug after the pharmaceutical company has thoroughly tested the product.
Even when the FDA approves a pharmaceutical, that does not mean that the prescription drug is risk-free. On the contrary, most every prescription drug can cause adverse effects for certain people. These side effects must be disclosed by the pharmaceutical companies and doctors must let patients know about the side effects before they prescribe a medication.
A prescription drug can face recall by the FDA if it is determined that the drug poses this severe threat to consumers that was not previously known.
The dangers of the prescription drug Elmiron
The prescription drug Elmiron (pentosan polysulfate sodium) is the only FDA-approved medication used to treat interstitial cystitis, or bladder pain syndrome. However, new research indicates the side effects of Elmiron may be more severe than was previously understood.
The testing of pharmaceutical drugs usually happens over the course of 2 to 5 years. While this is usually sufficient to discover most of the side effects related to taking a drug, sometimes issues are not discovered until long after a medication has been on the market.
Research strongly indicates that Elmiron can cause irreversible eye damage for patients who take the prescription drug over longer periods of time.
Despite the research from Dr. Nieraj Jain at the Emory Eye Center at the Emory School of Medicine in Atlanta, GA, and confirmation presented at the annual meeting of the American Academy of Ophthalmology in San Francisco, there have been no recalls of Elmiron.
Let us help with your Elmiron eye disease case
If you or somebody you care about has taken the prescription drug Elmiron, you may need to speak to an attorney as soon as possible. This pharmaceutical drug has been linked too serious and irreversible eye damage. At Colson Hicks Eidson, a nationally recognized firm has a reputation for helping clients who have been injured by defective drugs. Our goal is to secure the compensation you deserve, which can include:
Coverage of medical expenses related to the defective drug
Recovery of lost wages if you cannot work
Pain and suffering damages
Loss of enjoyment of life damages
Punitive damages against the manufacturer (Janssen Pharmaceuticals, Inc.)